GenScript Biotech Achieves EcoVadis Silver Medal for Sustainability Excellence

GenScript Biotech's Milestone in Sustainability

GenScript Biotech Corporation, a preeminent provider for life science research and manufacturing, is making headlines for its recent accolade: the EcoVadis Silver Medal. This prestigious recognition is the result of the company’s commitment to sustainability across key domains such as environmental impact, labor practices, ethics, and sustainable procurement. In achieving this feat, GenScript has solidified its place within the top 15% of all companies assessed worldwide by EcoVadis, a gold-standard platform known for evaluating corporate sustainability performance across numerous sectors.

Performance and Rankings

Upon reassessment, GenScript has positioned itself among the elite, outperforming approximately 85% of competitors globally and reaching the top 10% in pharmaceutical product manufacturing. With over 220 industry categories and 180 countries represented, EcoVadis utilizes an assessment methodology deeply rooted in international principles, including the United Nations Global Compact (UNGC) and ISO 26000. This thorough and rigorous review ensures that the organizations receiving accolades are genuinely committed to the sustainability agenda.

The Silver Medal serves as further affirmation of GenScript’s dedication to advancing a robust sustainability management framework. According to Sherry Shao, the Rotating CEO of GenScript Biotech, the achievement marks a significant milestone in their sustainability journey, emphasizing their ongoing commitment to environmental care, social responsibility, and ethical business practices.

Commitment to Sustainable Practices

Throughout its operations, GenScript has actively integrated sustainability into core business processes, thereby enhancing operational efficiency. The company has partnered with suppliers and stakeholders to build a responsible and sustainable supply chain that not only benefits the business ecosystem but also supports global sustainability goals. This dedication is evident in their established targets for carbon reduction, which have received the Science Based Targets initiative (SBTi) approval, further illustrating their proactive approach to combat climate change.

Moreover, GenScript is a proud member of the UNGC, firmly upholding principles related to human rights, labor conditions, environmental conservation, and anti-corruption measures. Their commitment to these values has gained them recognition from various international sustainability organizations and ratings entities.

Moving Forward: A Vision for Global Health

GenScript's future plans are firmly anchored in their mission: "Making People and Nature Healthier through Biotechnology." They aim to explore technological innovations that can spearhead growth in the life sciences industry while advocating for environmentally friendly practices. The company is determined to leverage international collaborations to streamline sustainability across all their global operations, maximize impact, and contribute positively to public health and sustainable development efforts.

With a workforce exceeding 5,500 employee and a client base of over 200,000 spanning more than 100 countries, GenScript is poised to be a substantial influence in the development of groundbreaking treatment methods and health-enhancing products in the biotech sector. As they continue this upward trajectory, their founding principles will guide them in fostering a greener, more responsible future capable of addressing the growing challenges faced within the life sciences landscape.

For further information about GenScript and their sustainability initiatives, visit GenScript's Website.